Identification of Nucleolin as a Novel AEG-1-Interacting Protein in Breast Cancer via Interactome Profiling.
AEG-1
LC-MS/MS
breast cancer
metastasis
nucleolin
protein-protein interaction
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
07 Jun 2021
07 Jun 2021
Historique:
received:
21
04
2021
revised:
03
06
2021
accepted:
03
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
3
7
2021
Statut:
epublish
Résumé
Breast cancer is one of the most common malignant diseases worldwide. Astrocyte elevated gene-1 (AEG-1) is upregulated in breast cancer and regulates breast cancer cell proliferation and invasion. However, the molecular mechanisms by which AEG-1 promotes breast cancer have yet to be fully elucidated. In order to delineate the function of AEG-1 in breast cancer development, we mapped the AEG-1 interactome via affinity purification followed by LC-MS/MS. We identified nucleolin (NCL) as a novel AEG-1 interacting protein, and co-immunoprecipitation experiments validated the interaction between AEG-1 and NCL in breast cancer cells. The silencing of NCL markedly reduced not only migration/invasion, but also the proliferation induced by the ectopic expression of AEG-1. Further, we found that the ectopic expression of AEG-1 induced the tyrosine phosphorylation of c-Met, and NCL knockdown markedly reduced this AEG-1 mediated phosphorylation. Taken together, our report identifies NCL as a novel mediator of the oncogenic function of AEG-1, and suggests that c-Met could be associated with the oncogenic function of the AEG-1-NCL complex in the context of breast cancer.
Identifiants
pubmed: 34200450
pii: cancers13112842
doi: 10.3390/cancers13112842
pmc: PMC8201222
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : National Research Foundation of Korea
ID : 2020R1F1A1073114
Organisme : National Research Foundation of Korea
ID : 2019R1A2C1090219
Organisme : Chungnam National University
ID : NA
Organisme : Korea Basic Science Institute
ID : C170100
Références
Breast Cancer. 2014 May;21(3):341-9
pubmed: 22903204
Cancer Cell. 2004 Apr;5(4):365-74
pubmed: 15093543
Cell Mol Life Sci. 2006 Sep;63(17):2016-26
pubmed: 16909210
Cancer Res. 2008 Mar 1;68(5):1478-84
pubmed: 18316612
Cancer Cell. 2009 Jan 6;15(1):9-20
pubmed: 19111877
EMBO J. 1999 Jul 1;18(13):3688-701
pubmed: 10393184
PLoS One. 2008 Jun 04;3(6):e2310
pubmed: 18523588
Nat Rev Cancer. 2013 May;13(5):299-314
pubmed: 23612459
Proc Natl Acad Sci U S A. 2009 Dec 15;106(50):21300-5
pubmed: 19940250
BMC Med Genomics. 2019 Jul 11;12(Suppl 5):101
pubmed: 31296229
Pharmaceutics. 2020 Jul 21;12(7):
pubmed: 32708267
J Biol Chem. 2003 Feb 21;278(8):5728-35
pubmed: 12475979
Cancer Res. 2011 Mar 15;71(6):2140-51
pubmed: 21257709
Oncotarget. 2016 Oct 4;7(40):65320-65334
pubmed: 27542246
Exp Cell Res. 2004 Mar 10;294(1):94-105
pubmed: 14980505
Biochem Biophys Res Commun. 2013 Oct 25;440(3):364-70
pubmed: 23998936
Breast Cancer Res Treat. 2000 Feb;59(3):245-54
pubmed: 10832594
Pharmacol Ther. 2011 Apr;130(1):1-8
pubmed: 21256156
Cancer Res. 2006 Feb 1;66(3):1509-16
pubmed: 16452207
Mol Carcinog. 2012 Aug;51(8):619-27
pubmed: 21809393
Cell Death Dis. 2018 Jan 19;9(2):47
pubmed: 29352243
Clin Cancer Res. 2008 Jun 1;14(11):3319-26
pubmed: 18519759
J Cancer Res Clin Oncol. 2010 Jun;136(6):911-21
pubmed: 20049476
PLoS One. 2009 Jul 03;4(7):e6128
pubmed: 19578540
Biochimie. 2015 Jun;113:78-85
pubmed: 25866190
PLoS One. 2008 Jun 18;3(6):e2518
pubmed: 18560571
J Agric Food Chem. 2011 Sep 14;59(17):9683-90
pubmed: 21806057
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Oncogene. 2008 Feb 14;27(8):1114-21
pubmed: 17704808
Biochemistry. 2011 May 10;50(18):3796-806
pubmed: 21466159
Adv Cancer Res. 2013;120:1-38
pubmed: 23889986
Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17390-5
pubmed: 17088530
PLoS One. 2013;8(1):e54674
pubmed: 23382938
APMIS. 2013 Oct;121(10):919-25
pubmed: 23763304
J Biol Chem. 2011 Jun 3;286(22):19982-92
pubmed: 21478147
J Clin Invest. 2009 Mar;119(3):465-77
pubmed: 19221438
Cancer Res. 2014 Dec 15;74(24):7321-32
pubmed: 25304263
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310
Int J Mol Sci. 2020 Dec 04;21(23):
pubmed: 33291786
Gene. 2005 Jun 20;353(1):8-15
pubmed: 15927426
Nat Commun. 2015 Apr 07;6:6658
pubmed: 25849741
Mol Cell Biol. 2017 Feb 15;37(5):
pubmed: 27956703
PLoS One. 2010 Dec 23;5(12):e15787
pubmed: 21203423
J Nucl Med. 2016 Feb;57 Suppl 1:9S-16S
pubmed: 26834110
Cancer Res. 2007 Nov 1;67(21):10491-500
pubmed: 17974993
J Cell Sci. 1999 Mar;112 ( Pt 6):761-72
pubmed: 10036227
J Exp Med. 2002 Oct 21;196(8):1067-78
pubmed: 12391018
J Exp Med. 2013 May 6;210(5):951-68
pubmed: 23610125
FASEB J. 1999 Nov;13(14):1911-22
pubmed: 10544174
J Biol Chem. 2001 Nov 16;276(46):43221-30
pubmed: 11555643
Breast Cancer Res Treat. 2012 Aug;135(1):49-58
pubmed: 22527098
Oncogene. 2002 May 16;21(22):3592-602
pubmed: 12032861